1. Home
  2. DHF vs QSI Comparison

DHF vs QSI Comparison

Compare DHF & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BNY Mellon High Yield Strategies Fund

DHF

BNY Mellon High Yield Strategies Fund

N/A

Current Price

$2.21

Market Cap

160.0M

Sector

Finance

ML Signal

N/A

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

N/A

Current Price

$1.06

Market Cap

165.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DHF
QSI
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.0M
165.6M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
DHF
QSI
Price
$2.21
$1.06
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $2.27
AVG Volume (30 Days)
529.4K
★ 6.8M
Earning Date
01-01-0001
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 28.17
EPS
★ N/A
N/A
Revenue
N/A
★ $2,436,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$451.30
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.12
$0.69
52 Week High
$2.57
$1.81

Technical Indicators

Market Signals
Indicator
DHF
QSI
Relative Strength Index (RSI) 45.76 42.19
Support Level $2.16 $1.05
Resistance Level $2.23 $1.30
Average True Range (ATR) 0.03 0.14
MACD -0.00 -0.05
Stochastic Oscillator 12.67 12.35

Price Performance

Historical Comparison
DHF
QSI

About DHF BNY Mellon High Yield Strategies Fund

BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. The fund invests predominantly in fixed-income securities of below-investment-grade credit quality.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Share on Social Networks: